Evidence map›Paper›PMID 36726762›Full record

ArticleProtein & cell2023

A core epitope targeting antibody of SARS-CoV-2.

Simeng Zhao, Fengjiang Liu, Shizhen Qiu, Qiaoshuai Lan, Yiran Wu, Wei Xu, Junzi Ke, Jie Yang, Xiaoyan Liu, Kun Wang and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Protein & cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Simeng ZhaoiHuman Institute, ShanghaiTech University, Shanghai 201210, China.ORCID 0000-0003-0372-0751
Fengjiang LiuShanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.
Shizhen QiuSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Qiaoshuai LanKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai 200032, China.
Yiran WuiHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Wei XuKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai 200032, China.
Junzi KeiHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Jie YangiHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Xiaoyan LiuiHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Kun WangSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Hangtian GuoShanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.
Shuai XiaKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai 200032, China.
Fangfang ZhangiHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Jiabei WangDepartment of Hepatobiliary Surgery, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, The University of Science and Technology of China, Hefei 230001, China.
Xiaowen HuDepartment of Pulmonary and Critical Care Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, The University of Science and Technology of China, Hefei 230026, China.
Lu LuKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai 200032, China.
Shibo JiangKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai 200032, China.ORCID 0000-0001-8283-7135
Suwen ZhaoiHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Lianxin LiuDivision of Life Sciences and Medicine, The First Affiliated Hospital of USTC, The University of Sciences and Technology of China, Hefei 230001, China.
Youhua XieKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai 200032, China.
Xiuna YangShanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.ORCID 0000-0003-3443-9815
Haopeng WangSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.ORCID 0000-0002-4995-0838
Guisheng ZhongiHuman Institute, ShanghaiTech University, Shanghai 201210, China.ORCID 0000-0003-0416-3774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2AntibodiesAntibodies, NeutralizingAntibodies, ViralHumansAntibodiesAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID36726762
PMCPMC9871958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.